NOTCH THERAPEUTICS

Notch Therapeutics is developing a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems... To broaden the applicability and accessibility of adoptive cell therapies, Notch Therapeutics has developed best-in-class, off-the-shelf, iPSC-derived T cells using our proprietary, small-footprint manufacturing system that allows us to produce synthetic T cells of unprecedented scale and functionality to further the advancement of cellular immunotherapies for patients and their families... With offices in Vancouver, Seattle, and Toronto, Notch Therapeutics operates on the traditional, ancestral, and unceded territories of the Musqueam, Squamish, and Tsleil-Waututh Nations; the ancestral land of the Duwamish, Suquamish, Stillaguamish, and Muckleshoot people; and the Treaty Lands and Territory of the Mississaugas of the Credit First Nation as well as the traditional territory of..

Also known as: Notch Therapeutics (Canada) Inc.

Primary location: Seattle United States